# US 5,707,655 A · Process for the preparation of medicament formulations with controlled release > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 5,707,655 A - Document ID: US5707655A - Status: Granted - Kind: A - Application number: 08/701,410 - Filed: 1996-08-22 - Granted: 1998-01-13 - Earliest claimed: 1995-08-29 - Assignees: Bayer Aktiengesellschaft - Inventors: Venkata-Rangarao Kanikanti; Stefan Kettelhoit; Peter Kurka; Gunther Penners; Peter Serno - Web page: https://patentgrep.com/patent/US5707655A ## CPC - A61K 9/2054: {Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose} - A61K 9/2027: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates} - A61K 9/2095: {Tabletting processes} - A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D) ## Abstract The invention relates to a special process for the preparation of stable, solid medicament formulations of high bioavailability and with controlled release comprising sparingly soluble active compounds and polymeric auxiliaries, and to the formulations thus prepared. ## Claims ### Claim 1 A process for preparing a controlled release, solid medicament formulations which possess high stability, said process comprises: A. mixing in the absence of solvents at least three components which comprise at least one part by weight of a sparingly soluble and heat-stable active compound (I); 0.5 to 50 parts by weight of a cellulose ether (II); and 0.5 to 50 parts by weight of a polyoctam or polyvinyllactam copolymer (III) B. shaping the solid mixture obtained above to give the desired medicament formulation; and C. heating the shaped formulation obtained above at a temperature between 50.degree. and 200.degree. C. for at least 30 minutes to achieve thermal dissolution or amorphization of the active compound. ### Claim 2 (depends on 1) The process according to claim 1, characterized in that cellulose ethers having methoxy and hydroxypropyl substituents which have a viscosity of 15 to 100,000 mPa.smallcircle.s in 2% strength aqueous solution are employed as constituent (II). ### Claim 3 (depends on 1) The process according to claim 1, characterized in that polyvinylpyrrolidone or vinylpyrrolidone/vinyl acetate copolymer which has an average molecular weight of 20,000 to 2,000,000 MW is employed as constituent (III). ### Claim 4 (depends on 1) Solid medicament formulations prepared according to the process of claim 1. ### Claim 5 (depends on 1) The process according to claim 1, wherein the heating step is carried out at a temperature of 80.degree. to 170.degree. C. for a time period of 30 minutes to 48 hours. ### Claim 6 (depends on 1) The process according to claim 1, wherein the sparingly soluble active compound is a dihydropyridine. ### Claim 7 (depends on 1) The process according to claim 1, wherein the solid medicament formulation is in the shape of a tablet, pellet or granules. ### Claim 8 (depends on 1) The process according to claim 1, wherein the heating step is carried out at a temperature between 50.degree. and 200.degree. C. for a time period of 30 minutes to 72 hours. ### Claim 9 (depends on 1) The process according to claim 1 wherein A. mixing in the absence of solvents three components which comprise 5 to 50 parts by weight of a dihydropyridine compound, 20 to 45 parts by weight of a cellulose ether having methoxy and hydroxypropyl substituents and having a viscosity of 15 to 100,000 mPa.smallcircle.s in a 2% strength aqueous solution; and 20 to 40 parts by weight of a polyvinylpyrrolidone or vinylpyrrolidone/vinyl acetate copolymer, which has an average molecular weight of 20,000 to 2,000,000 MW; B. shaping the mixture obtained above into a tablet; and C. heating the tablet obtained above at a temperature of 80.degree. C. to 170.degree. C. for a time period between 30 minutes and 48 hours to achieve thermal dissolution or amorphization of the active compound.